NCT06064617

Brief Summary

Addition lenses are often used to treat a range of eye conditions. Addition lenses are specifically used to help patients who do not have the ability to focus their eyes to see clearly up close. Eye focusing is called accommodation. Addition lenses are easy to prescribe in a pair of glasses and are often called the bifocal portion of the glasses. Addition lenses can be used for adults who have presbyopia (they cannot read up close without the aide of a bifocal) and for patients of all ages who have eye focusing problems (e.g. accommodative insufficiency, accommodative infacility, accommodative dysfunction). Addition powers can also be put into contact lenses. Contact lenses that have addition powers in them are called multifocal contact lenses. These are often marketed for patients that are 40 and over who have presbyopia, and are prescribed to help patients see up close as well as far away in their contact lenses. Multifocal contact lenses are also used in children with nearsightedness because studies have shown that some multifocal designs can slow down the progression of nearsightedness. As stated before, addition lenses can be used to treat eye focusing problems in patients of all ages, before presbyopia. What is unclear is whether the addition power in contact lenses has the same treatment effect as an addition power in a pair of glasses when they are being used to treat eye focusing problems. This study will assess how different kinds of multifocal contact lenses (center distance or center near) will change eye focusing and eye teaming in young adult patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 3, 2023

Completed
29 days until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

January 8, 2026

Completed
Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

September 14, 2023

Results QC Date

July 29, 2025

Last Update Submit

January 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Objective Accommodative Response (in Diopters) on the Grand Seiko Autorefractor at 2.5 Diopters (40 cm)

    Accommodative function will be compared using the Grand Seiko Autorefractor between the center distance and center near group. The instrument will record the patient's refractive error at near (40 cm), which is commonly used for near assessment in clinic. Patients place their head on a chin rest and look at targets at different distances. The examiner then pushes a button and the refractive error (in Diopters) is recorded from the instrument and placed in an excel file to be analyzed.

    Up to two hours (1 hour in each lens)

Secondary Outcomes (5)

  • Accommodation (in Diopters) Measured by Monocular Estimation Method (MEM)

    Up to two hours

  • Accommodation (in Diopters) Measured by Monocular Push-Up

    Up to 2 hours

  • Accommodation (in Cycles Per Minute) Measured by Accommodative Facility

    Up to 2 hours

  • Phoria (in Prism Diopters) Measured by Modified Thorington at Distance

    Up to 2 Hours

  • Phoria (in Prism Diopters) Measured by Modified Thorington at Near

    Up to 2 hours

Study Arms (2)

Center Distance then Center Near Multifocal Contact Lens

EXPERIMENTAL

All participants will wear a Biofinity center distance multifocal contact lens with a +2.50 add and measurements will be obtained. Then participants will wear a Biofinity center near multifocal contact lens with a +2.50 add and measurements will be obtained.

Device: Center-Near (+2.50D) Coopervision Biofinity Multifocal Contact LensDevice: Center Distance (+2.50 D) Coopervision Biofinity Multifocal Contact Lens

Center Near then Center Distance Multifocal Contact Lens

EXPERIMENTAL

All participants will wear a Biofinity center near multifocal contact lens with a +2.50 add and measurements will be obtained. Then all participants will wear a Biofinity center distance multifocal contact lens with a +2.50 add and measurements will be obtained.

Device: Center-Near (+2.50D) Coopervision Biofinity Multifocal Contact LensDevice: Center Distance (+2.50 D) Coopervision Biofinity Multifocal Contact Lens

Interventions

Center-Near multifocal design

Center Distance then Center Near Multifocal Contact LensCenter Near then Center Distance Multifocal Contact Lens

Center-Distance multifocal design

Center Distance then Center Near Multifocal Contact LensCenter Near then Center Distance Multifocal Contact Lens

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18 to ≤ 30 years old
  • Acuity of 20/25 or better in both eyes with habitual contact lens prescription
  • No history of ocular disease or active ocular inflammation
  • No history of ocular or refractive surgery
  • No current history of rigid contact lens wear
  • Astigmatism ≤1.00 D
  • Free of binocular vision disorder (strabismus, amblyopia, vergence dysfunction, accommodative dysfunction)

You may not qualify if:

  • No prior or concurrent participation in myopia control or use of low dose atropine, multifocal contact lenses
  • No use of any medications suspected to affect accommodation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Limitations and Caveats

The participants were not allowed to adapt to the contact lenses outside of the office - all testing was done in office and participants were not allowed to take the contact lenses out of the office.

Results Point of Contact

Title
Ann Morrison
Organization
The Ohio State University

Study Officials

  • Ann M Morrison, OD, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know what lens they are in
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This study will be an observational single-center investigation using a cross sectional design and each subject will undergo two test sessions and will wear two different contact lenses. Each test session will take approximately 2 hours. The two arms are as follow: * Center-Distance (+2.50D add) then Center-Near (+2.50D add) * Center-Near (+2.50D add) then Center-Distance (+2.50D add)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 14, 2023

First Posted

October 3, 2023

Study Start

November 1, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

January 8, 2026

Results First Posted

January 8, 2026

Record last verified: 2026-01

Locations